Literature DB >> 28007621

Instability of Willingness to Accept Life-Sustaining Treatments in Patients With Advanced Chronic Organ Failure During 1 Year.

Carmen H M Houben1, Martijn A Spruit2, Jos M G A Schols3, Emiel F M Wouters4, Daisy J A Janssen5.   

Abstract

BACKGROUND: For optimal end-of-life decision-making, it is important to understand the stability of patients' treatment preferences. The aim of this paper is to examine the stability of willingness to accept life-sustaining treatments during 1-year follow-up in Dutch patients with advanced chronic organ failure. In addition, we want to explore the association between willingness to accept high-burden treatment and preferences for CPR and mechanical ventilation (MV).
METHODS: In this multicenter longitudinal study, 265 clinically stable outpatients with advanced COPD (Global Initiative for Chronic Obstructive Lung Disease stage III/IV [n = 105]), chronic heart failure (New York Heart Association class III/IV [n = 80]), or chronic renal failure (requiring dialysis [n = 80) were visited at baseline and at 4, 8, and 12 months to assess the stability of life-sustaining treatment preferences using the Willingness to Accept Life-sustaining Treatment instrument.
RESULTS: Two hundred six patients completed 1-year follow-up (mean age, 67.2 years [SD, 13.1 years]; 64.1% men). Overall, proportions of patients who were willing to accept life-sustaining treatment during 1 year did not change over time. However, individual trajectories showed that about two-thirds of patients changed their preferences at least once during a year. Moreover, there was no association found between the stability of willingness to undergo high-burden therapy and the stability of preferences for CPR and MV.
CONCLUSIONS: The current findings show the complexity of preferences for end-of-life care and indicate once again that advance care planning is a continuous process between patients and physicians, in which preferences for specific situations are discussed and that needs to be regularly reevaluated to deliver high-quality end-of-life care. CLINICAL TRIAL REGISTRATION: Netherlands National Trial Register (NTR 1552).
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  communication; end of life; life-sustaining treatments; palliative care

Mesh:

Year:  2016        PMID: 28007621     DOI: 10.1016/j.chest.2016.12.003

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  Pragmatic methods to avoid intensive care unit admission when it does not align with patient and family goals.

Authors:  Nita Khandelwal; Ann C Long; Robert Y Lee; Cara L McDermott; Ruth A Engelberg; J Randall Curtis
Journal:  Lancet Respir Med       Date:  2019-05-20       Impact factor: 30.700

2.  Clustering of patients with end-stage chronic diseases by symptoms: a new approach to identify health needs.

Authors:  Panaiotis Finamore; Martijn A Spruit; Jos M G A Schols; Raffaele Antonelli Incalzi; Emiel F M Wouters; Daisy J A Janssen
Journal:  Aging Clin Exp Res       Date:  2020-04-11       Impact factor: 3.636

3.  Care preferences in physician orders for life sustaining treatment in California nursing homes.

Authors:  Lee A Jennings; Neil S Wenger; Li-Jung Liang; Punam Parikh; David Powell; Jose J Escarce; David Zingmond
Journal:  J Am Geriatr Soc       Date:  2022-03-11       Impact factor: 7.538

4.  Effect of the Family-Centered Advance Care Planning for Teens with Cancer Intervention on Sustainability of Congruence About End-of-Life Treatment Preferences: A Randomized Clinical Trial.

Authors:  Jennifer Susan Needle; Sarah Friebert; Jessica D Thompkins; Daniel H Grossoehme; Justin N Baker; JiJi Jiang; Jichuan Wang; Maureen E Lyon
Journal:  JAMA Netw Open       Date:  2022-07-01

5.  Dialysis Patients' Preferences on Resuscitation: A Cross-Sectional Study Design.

Authors:  Husam Alzayer; Annette M Geraghty; Kuruvilla K Sebastian; Hardarsh Panesar; Donal N Reddan
Journal:  Can J Kidney Health Dis       Date:  2022-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.